Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maybuck Group (Hebei Maybuck Group Co., Ltd.) is a Chinese biotechnology and medical device company specializing in regenerative medicine and wound care. The company's core scientific research is centered on its proprietary tissue cell in situ regeneration and repair technology, which is designed to treat deep burns, diabetic foot ulcers, and other difficult-to-heal wounds without requiring skin grafting or amputation. Maybuck Group's product portfolio includes the Buck sterile dressing and the Barnak (or Banake) line of antibacterial skincare products, such as the Barnak Gold Yu Fu Cream. The company operates across China, collaborating with academic institutions like the Peking University Health Science Center to advance clinical research and standardize regenerative medicine treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maybuck Group.